Literature DB >> 25008195

The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients.

M Papadimitriou-Olivgeris1, M Christofidou, F Fligou, C Bartzavali, T Vrettos, K S Filos, M Marangos, E D Anastassiou.   

Abstract

PURPOSE: To identify the risk factors for incident enteric colonization by KPC-producing Klebsiella pneumoniae (KPC-Kp) resistant to colistin or tigecycline during Intensive Care Unit (ICU) stay.
METHOD: A prospective observational study of patients admitted to the ICU was conducted during a 27-month period. Rectal samples taken upon admission and weekly afterwards were inoculated on selective chromogenic agar. K. pneumoniae isolates were characterized by standard methodology. Mean inhibitory concentration (MIC) to colistin and tigecycline were determined by E-test. The presence of bla KPC gene was confirmed by PCR.
RESULTS: Among 254 patients, 62 (24.4%) became colonized by colistin- resistant KPC-Kp during their stay. Multivariate analysis revealed that corticosteroid, colistin administration and number of colonized patients in nearby beds per day were significantly associated with colonization. Among 257 patients, 39 (17.9%) became colonized by tigecycline resistant KPC-Kp during their stay. Risk factors identified by multivariate analysis were: days at risk, obesity, number of colonized patients treated in nearby beds per day and administration of tigecycline.
CONCLUSIONS: The high prevalence of colistin or tigecycline resistant KPC-Kp enteric carriage in ICU patients indicate that dissemination is due to their transfer from patient to patient via the personnel and indicates the importance of strict infection control protocols.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25008195     DOI: 10.1007/s15010-014-0653-x

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  24 in total

1.  Use of corticosteroid is a risk factor for nosocomial infection in paediatric patients.

Authors:  L L L Moreira; E M Netto; C M Nascimento-Carvalho
Journal:  J Hosp Infect       Date:  2008-12-13       Impact factor: 3.926

2.  KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality.

Authors:  Matthaios Papadimitriou-Olivgeris; Markos Marangos; Fotini Fligou; Myrto Christofidou; Christina Sklavou; Sophia Vamvakopoulou; Evangelos D Anastassiou; Kriton S Filos
Journal:  Diagn Microbiol Infect Dis       Date:  2013-07-23       Impact factor: 2.803

Review 3.  Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects.

Authors:  Rosemeri Maurici da Silva; Jefferson Traebert; Dayani Galato
Journal:  Expert Opin Biol Ther       Date:  2012-04-16       Impact factor: 4.388

4.  Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.

Authors:  Zubair A Qureshi; David L Paterson; Brian A Potoski; Mary C Kilayko; Gabriel Sandovsky; Emilia Sordillo; Bruce Polsky; Jennifer M Adams-Haduch; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

Review 5.  ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.

Authors:  E Tacconelli; M A Cataldo; S J Dancer; G De Angelis; M Falcone; U Frank; G Kahlmeter; A Pan; N Petrosillo; J Rodríguez-Baño; N Singh; M Venditti; D S Yokoe; B Cookson
Journal:  Clin Microbiol Infect       Date:  2014-01       Impact factor: 8.067

Review 6.  Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.

Authors:  P Nordmann
Journal:  Med Mal Infect       Date:  2013-12-18       Impact factor: 2.152

7.  Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission.

Authors:  Matthaios Papadimitriou-Olivgeris; Markos Marangos; Fotini Fligou; Myrto Christofidou; Christina Bartzavali; Evangelos D Anastassiou; Kriton S Filos
Journal:  J Antimicrob Chemother       Date:  2012-08-26       Impact factor: 5.790

Review 8.  Obesity and infection: two sides of one coin.

Authors:  Giulia Genoni; Flavia Prodam; Agostina Marolda; Enza Giglione; Irene Demarchi; Simonetta Bellone; Gianni Bona
Journal:  Eur J Pediatr       Date:  2013-10-22       Impact factor: 3.183

9.  Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece).

Authors:  H C Maltezou; P Giakkoupi; A Maragos; M Bolikas; V Raftopoulos; H Papahatzaki; G Vrouhos; V Liakou; A C Vatopoulos
Journal:  J Infect       Date:  2009-02-26       Impact factor: 6.072

10.  Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients.

Authors:  Nikolaos Markou; Haralampos Apostolakos; Christiana Koumoudiou; Maria Athanasiou; Alexandra Koutsoukou; Ioannis Alamanos; Leonidas Gregorakos
Journal:  Crit Care       Date:  2003-07-28       Impact factor: 9.097

View more
  17 in total

1.  Frequency of and risk factors for carbapenem-resistant Enterobacteriaceae.

Authors:  Katie E Barber; Jamie L Wagner; Rachel C Larry; Kayla R Stover
Journal:  J Med Microbiol       Date:  2021-02       Impact factor: 2.472

2.  Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?

Authors:  Nenad Macesic; Brian Nelson; Anne-Catrin Uhlemann
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079

3.  XDR-Klebsiella pneumoniae isolates harboring blaOXA-48: In vitro and in vivo evaluation using a murine thigh-infection model.

Authors:  Noha A Kamel; Wafaa N El-Tayeb; Mona R El-Ansary; Mohamed T Mansour; Khaled M Aboshanab
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-31

4.  Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of an mgrB Deletion Mutant.

Authors:  Tommaso Giani; Fabio Arena; Guendalina Vaggelli; Viola Conte; Adriana Chiarelli; Lucia Henrici De Angelis; Rossella Fornaini; Maddalena Grazzini; Fabrizio Niccolini; Patrizia Pecile; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

5.  Modelling of the transmission dynamics of carbapenem-resistant Klebsiella pneumoniae in hospitals and design of control strategies.

Authors:  Suttikiat Changruenngam; Charin Modchang; Dominique J Bicout
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.996

6.  A model for predicting nosocomial carbapenem-resistant Klebsiella pneumoniae infection.

Authors:  Duo Yang; Zeqiang Xie; Xuli Xin; Wenying Xue; Man Zhang
Journal:  Biomed Rep       Date:  2016-09-07

Review 7.  Bloodstream infections in internal medicine.

Authors:  Valerio Del Bono; Daniele Roberto Giacobbe
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

8.  Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Kalisvar Marimuthu; Oon Tek Ng; Benjamin Pei Zhi Cherng; Raymond Kok Choon Fong; Surinder Kaur Pada; Partha Pratim De; Say Tat Ooi; Nares Smitasin; Koh Cheng Thoon; Prabha Unny Krishnan; Michelle Lay Teng Ang; Douglas Su Gin Chan; Andrea Lay Hoon Kwa; Rama Narayana Deepak; Yu Kit Chan; Yvonne Fu Zi Chan; Xiaowei Huan; Kyaw Zaw Linn; Nancy Wen Sim Tee; Thean Yen Tan; Tse Hsien Koh; Raymond Tzer Pin Lin; Li Yang Hsu; Sharmila Sengupta; David L Paterson; Eli Perencevich; Stephan Harbarth; Jeanette Teo; Indumathi Venkatachalam
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

9.  The Role of Obesity in Sepsis Outcome among Critically Ill Patients: A Retrospective Cohort Analysis.

Authors:  Matthaios Papadimitriou-Olivgeris; Diamanto Aretha; Anastasia Zotou; Kyriaki Koutsileou; Aikaterini Zbouki; Aikaterini Lefkaditi; Christina Sklavou; Markos Marangos; Fotini Fligou
Journal:  Biomed Res Int       Date:  2016-09-29       Impact factor: 3.411

10.  Risk factors for acquisition of colistin-resistant Klebsiella pneumoniae and expansion of a colistin-resistant ST307 epidemic clone in hospitals in Marseille, France, 2014 to 2017.

Authors:  Sophie Alexandra Baron; Nadim Cassir; Mouna Hamel; Linda Hadjadj; Nadia Saidani; Gregory Dubourg; Jean-Marc Rolain
Journal:  Euro Surveill       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.